Blood test for Alzheimer's goes on sale without FDA approval
St. Louis-based C2N Diagnostics has released a blood test that it says can detect Alzheimer's disease. The test is not yet FDA approved, and is not covered by insurance, costing up to $1,250. Northwell Health internal medicine specialist Dr. Karen Abrashkin joins CBSN's Anne-Marie Green to talk about the latest development in the fight against Alzheimer's, which affects nearly 6 million Americans.
UP NEXT
UP NEXT
-
Georgia Fire captain delivers Pledge of Allegiance using sign language on Inauguration Day
CBS News
-
TV icon Larry King has died at age 87
CBS News
-
Dr. John LaPook on the state of COVID-19 vaccine distribution
CBS News
-
U.S. faces vaccine crisis over supply problems
CBS News
-
Biden administration vows to improve coronavirus response
CBS News
-
"CBS Weekend News" headlines for Saturday, January 23, 2021
CBS News
-
Previewing the NFL's conference championship Sunday
CBS News
-
Stormy weather pattern setting up across the U.S.
CBS News
-
From 2006: Talking TV with Larry King
CBS News
-
President Biden kicks off term with flurry of executive orders
CBS News
-
Winning $1 billion Mega Millions ticket sold in Michigan
CBS News
-
U.S. works to get more COVID-19 vaccine doses amid concerns over new variant
CBS News
-
Domestic extremist groups adapting online despite social media crackdowns
CBS News
-
Birx suggests inauguration-related gatherings could be "superspreader"
CBS News
-
The Dish: Vanessa Price on wine pairings for the real world
CBS News
-
Buffalo Bills fans raise money for Baltimore Ravens quarterback's favorite charity
CBS News